Recent immunologic advances affecting the management of ovarian cancer.
作者信息
Freedman R S
出版信息
Clin Obstet Gynecol. 1985 Dec;28(4):853-71. doi: 10.1097/00003081-198528040-00020.
Abstract
摘要
相似文献
1
Recent immunologic advances affecting the management of ovarian cancer.影响卵巢癌治疗的近期免疫学进展。
Clin Obstet Gynecol. 1985 Dec;28(4):853-71. doi: 10.1097/00003081-198528040-00020.
2
Ovarian carcinoma therapy with monoclonal antibodies.单克隆抗体治疗卵巢癌
Hybridoma. 1993 Oct;12(5):501-7. doi: 10.1089/hyb.1993.12.501.
3
Antitumor antibodies for immunotherapy of ovarian carcinomas.用于卵巢癌免疫治疗的抗肿瘤抗体。
Hybridoma. 1993 Oct;12(5):521-8. doi: 10.1089/hyb.1993.12.521.
4
Immunotherapy for ovarian cancer.
Curr Opin Oncol. 1990 Oct;2(5):893-900. doi: 10.1097/00001622-199010000-00015.
5
Immunologic approaches to the management of ovarian carcinoma.
Semin Oncol. 1984 Sep;11(3):264-74.
6
Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab.用抗体对卵巢癌进行免疫治疗：聚焦于奥瑞珠单抗。
Expert Opin Biol Ther. 2004 Jul;4(7):1159-65. doi: 10.1517/14712598.4.7.1159.
7
Role of novel adjuvants in specific active immunotherapy.
Prog Clin Biol Res. 1989;288:297-307.
8
The fourth modality: immunotherapy for head and neck cancer hits pay dirt.第四种治疗方式：头颈癌免疫疗法取得成功。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Jun;121(6):575-7. doi: 10.1016/j.oooo.2016.03.019. Epub 2016 Apr 7.
9
Biologic and immunologic therapy of ovarian cancer.卵巢癌的生物治疗与免疫治疗
Hematol Oncol Clin North Am. 1992 Aug;6(4):941-65.
10
[Taktivin in the combined treatment of patients with ovarian cancer].
Akush Ginekol (Mosk). 1988 Aug(8):57-61.
引用本文的文献
1
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer.增强抗肿瘤自然杀伤细胞功能治疗卵巢癌。
Int J Mol Sci. 2019 Feb 19;20(4):890. doi: 10.3390/ijms20040890.
2
Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.基于自然杀伤细胞的免疫疗法在妇科恶性肿瘤中的应用：综述
Front Immunol. 2018 Jan 5;8:1825. doi: 10.3389/fimmu.2017.01825. eCollection 2017.
Zotero 插件